CEE: Schoenherr advises Mutares on the acquisition of Synthomer a.s.

Schoenherr advised Mutares on all Austrian legal aspects of the transaction. The acquisition represents a strategic platform investment for Mutares' Chemicals & Materials segment and is fully aligned with the company's strategy of acquiring businesses in transition with significant operational improvement potential.

Synthomer a.s. is Synthomer plc's Czech-based Acrylate Monomers segment and a leading European producer and supplier of acrylic acids and acrylic esters serving a wide range of industrial applications. The company benefits from an integrated product portfolio and a highly flexible production set-up, enabling the optimisation of product mix and margins. In 2025, Synthomer a.s. generated revenues of approximately EUR 110m (carve-out revenues) and employed around 300 people.

"We are pleased to have supported Mutares on this strategically important acquisition," said Schoenherr partner Alfred Amann, who led the advisory team. "The transaction highlights the continued appetite for complex carve-out opportunities and demonstrates the value creation potential that can be unlocked through the successful transformation of established industrial businesses."

Headquartered in Munich, Mutares is a listed private equity holding company specialising in the acquisition of companies in transition with significant operational improvement potential. Through its international network of offices, Mutares acquires, stabilises and repositions businesses across a broad range of industries.

The team further included Alexandra Jelinek (Associate), Michal Jendželovský (Partner), Kristýna Zmatlíková (Attorney at Law), Vladimír Čížek (Partner), Helena Hangler (Counsel), Marie Gremillot (Attorney at Law) , Sebastian Špeta (Attorney at Law), Christoph Jirak (Partner) and Patrick Petschinka (Attorney at Law).

Michal Ondroušek, Milan Tomíček and Ondřej Dráb from Staněk, Tomíček & Partners advised on aspects of Czech tax law.